- Home
- NLSP vs JZXN Comparison
NLSP vs JZXN Comparison
Compare NLSP & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- JZXN
- Stock Information
- Founded
- NLSP 2015
- JZXN 2019
- Country
- NLSP Switzerland
- JZXN China
- Employees
- NLSP N/A
- JZXN N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- JZXN Retail-Auto Dealers and Gas Stations
- Sector
- NLSP Health Care
- JZXN Consumer Discretionary
- Exchange
- NLSP Nasdaq
- JZXN Nasdaq
- Market Cap
- NLSP 12.4M
- JZXN 11.9M
- IPO Year
- NLSP 2021
- JZXN 2021
- Fundamental
- Price
- NLSP $1.95
- JZXN $0.94
- Analyst Decision
- NLSP
- JZXN
- Analyst Count
- NLSP 0
- JZXN 0
- Target Price
- NLSP N/A
- JZXN N/A
- AVG Volume (30 Days)
- NLSP 171.1K
- JZXN 84.1K
- Earning Date
- NLSP 08-12-2025
- JZXN 09-08-2025
- Dividend Yield
- NLSP N/A
- JZXN N/A
- EPS Growth
- NLSP N/A
- JZXN N/A
- EPS
- NLSP N/A
- JZXN N/A
- Revenue
- NLSP N/A
- JZXN $97,465.00
- Revenue This Year
- NLSP N/A
- JZXN N/A
- Revenue Next Year
- NLSP N/A
- JZXN N/A
- P/E Ratio
- NLSP N/A
- JZXN N/A
- Revenue Growth
- NLSP N/A
- JZXN N/A
- 52 Week Low
- NLSP $1.30
- JZXN $0.84
- 52 Week High
- NLSP $8.35
- JZXN $7.82
- Technical
- Relative Strength Index (RSI)
- NLSP 37.66
- JZXN 37.99
- Support Level
- NLSP $1.71
- JZXN $0.90
- Resistance Level
- NLSP $2.00
- JZXN $1.28
- Average True Range (ATR)
- NLSP 0.15
- JZXN 0.14
- MACD
- NLSP -0.03
- JZXN 0.05
- Stochastic Oscillator
- NLSP 21.67
- JZXN 10.26
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.